KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeMD (LFMD) Equity Ratio (2016 - 2025)

LifeMD filings provide 14 years of Equity Ratio readings, the most recent being 0.33 for Q4 2025.

  • On a quarterly basis, Equity Ratio rose 431.29% to 0.33 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.33, a 431.29% increase, with the full-year FY2025 number at 0.33, up 431.29% from a year prior.
  • Equity Ratio hit 0.33 in Q4 2025 for LifeMD, up from 0.05 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.47 in Q1 2022 to a low of 3.2 in Q1 2025.
  • Median Equity Ratio over the past 5 years was 0.04 (2022), compared with a mean of 0.25.
  • Biggest five-year swings in Equity Ratio: skyrocketed 1152.97% in 2022 and later crashed 8320.94% in 2025.
  • LifeMD's Equity Ratio stood at 0.43 in 2021, then plummeted by 206.37% to 0.46 in 2022, then soared by 115.49% to 0.07 in 2023, then crashed by 238.59% to 0.1 in 2024, then soared by 431.29% to 0.33 in 2025.
  • The last three reported values for Equity Ratio were 0.33 (Q4 2025), 0.05 (Q3 2025), and 0.03 (Q2 2025) per Business Quant data.